Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34491
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18259/20457 (89%)
Visitors : 6537266      Online Users : 788
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34491


    Title: The Biosafety and Risk Management in Preparation and Processing of Cerebrospinal Fluid and Other Neurological Specimens With Potential Coronavirus Infection
    Authors: Chen, Chien-Chin
    Chiang, Pei-Chun
    Chen, Tsung-Hsien
    Contributors: Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Pathol
    Chia Nan Univ Pharm & Sci, Dept Cosmet Sci
    Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med
    Keywords: COVID-19
    CSF
    neurology
    coronavirus
    cytology
    biosafety
    myopathy
    neuromuscular
    Date: 2021
    Issue Date: 2023-11-11 11:57:13 (UTC+8)
    Publisher: FRONTIERS MEDIA SA
    Abstract: The recent outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2, has become a global threat. Due to neurological manifestations presented throughout the coronavirus disease process, the potential involvement of COVID-19 in central nervous system has attracted considerable attention. Notably, the neurologic system could be widely affected, with various complications such as acute cerebrovascular events, encephalitis, Guillain-Barre syndrome, and acute necrotizing hemorrhagic encephalopathy. However, the risk assessment of exposure to potential biohazards in the context of the COVID-19 pandemic has not been clearly clarified regarding the sampling, preparation, and processing neurological specimens. Further risk managements and implantations are seldom discussed either. This article aims to provide current recommendations and evidence-based reviews on biosafety issues of preparation and processing of cerebrospinal fluid and neurological specimens with potential coronavirus infection from the bedside to the laboratory.
    Relation: FRONT NEUROL, v.11, 613552
    Appears in Collections:[Dept. of Cosmetic Science and institute of cosmetic science] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    fneur.2020.613552.pdf213KbAdobe PDF117View/Open
    index.html0KbHTML199View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback